Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Etiology and pathogenesis of sarcopenia, the progressive decline in skeletal muscle mass and strength that occurs with aging, are still poorly understood. We recently found that overexpression of the neural serine protease neurotrypsin in motoneurons resulted in the degeneration of their neuromuscular junctions (NMJ) within days. Therefore, we wondered whether neurotrypsin‐dependent NMJ degeneration also affected the structure and function of the skeletal muscles. Using histological and functional analyses of neurotrypsin‐overexpressing and neurotrypsin‐deficient mice, we found that overexpression of neurotrypsin in motoneurons installed the full sarcopenia phenotype in young adult mice. Characteristic muscular alterations included a reduced number of muscle fibers, increased heterogeneity of fiber thickness, more centralized nuclei, fiber‐type grouping, and an increased proportion of type I fibers. As in age‐dependent sarcopenia, excessive fragmentation of the NMJ accompanied the muscular alterations. These results suggested the destabilization of the NMJ through proteolytic cleavage of agrin at the onset of a pathogenic pathway ending in sarcopenia. Studies of neurotrypsin‐deficient and agrin‐overexpressing mice revealed that old‐age sarcopenia also develops without neurotrypsin and is not prevented by elevated levels of agrin. Our results define neurotrypsin‐ and age‐dependent sarcopenia as the common final outcome of 2 etiologically distinct entities.—Bütikofer, L., Zurlinden, A., Bolliger, M. F., Kunz, B., Sonderegger, P. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB J. 25, 4378–4393 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 1×
“Sarcopenia, the progressive decline in skeletal muscle mass and function that occurs with aging, contributes substantially to impaired mobility of the elderly and has been associated with an increased risk of morbidity, disability, and mortality (1, 2).”
BackgroundInvited Review: Aging and sarcopenia
Doherty, T. J. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00347.2003 · Cited by 1,764
Human growth hormone and human aging
CORPAS, E., HARMAN, S. M., & BLACKMAN, M. R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-20 · Cited by 911
An adaptive coding model of neural function in prefrontal cortex
Duncan, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097575 · Cited by 874
Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., LeBrasseur, N. K., Yan, Z., & Spiegelman, B. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704817200 · Cited by 611
Neural control of aging skeletal muscle
Delbono, O. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00011.x · Cited by 248 · cited 1×
“31), physical inactivity (32), oxidative damage (35), impaired excitation-contraction coupling (36), decline in satellite cell activation, and proliferation (14, 37), as well as nutritional, hormonal, metabolic, and immunological deficits associated with advanced age (38–43).”
BackgroundPicard, M., Ritchie, D., Wright, K. J., Romestaing, C., Thomas, M. M., Rowan, S. L., Taivassalo, T., & Hepple, R. T. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00628.x · Cited by 238 · cited 1×
“Mitochondrial dysfunction has also been discussed as an etiology for sarcopenia (7, 33); however, the extent of the mitochondrial contribution to sarcopenia may have been overestimated (34).”
BackgroundMitochondrial abnormalities are more frequent in muscles undergoing sarcopenia
Bua, E. A., McKiernan, S. H., Wanagat, J., McKenzie, D., & Aiken, J. M. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01102.2001 · Cited by 223 · cited 1×
“Mitochondrial dysfunction has also been discussed as an etiology for sarcopenia (7, 33); however, the extent of the mitochondrial contribution to sarcopenia may have been overestimated (34).”
Background
Cited by
Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting
Tintignac, L. A., Brenner, H.-R., & Rüegg, M. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00033.2014 · Cited by 422
Innervation and neuromuscular control in ageing skeletal muscle
Hepple, R. T., & Rice, C. L. (2016) · The Journal of Physiology · doi:10.1113/jp270561 · Cited by 400
Neuromuscular Junction Formation, Aging, and Disorders
Li, L., Xiong, W.-C., & Mei, L. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034255 · Cited by 370
The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle
Gonzalez-Freire, M., de Cabo, R., Studenski, S. A., & Ferrucci, L. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00208 · Cited by 356
Cesari, M., Fielding, R. A., Pahor, M., Goodpaster, B., Hellerstein, M., Van Kan, G. A., Anker, S. D., Rutkove, S., Vrijbloed, J. W., Isaac, M., et al. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-012-0078-2 · Cited by 285
Metadata
- Authors
- Bütikofer, L., Zurlinden, A., Bolliger, M. F., Kunz, B., & Sonderegger, P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2011-09
- Volume
- 25
- Issue
- 12
- Pages
- 4378-4393
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2103415764
- Cited by
- 138
- References
- 8
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. https://app.cochat.ai/papers/10.1096/fj.11-191262
- The paper
- Bütikofer, L., Zurlinden, A., Bolliger, M. F., Kunz, B., & Sonderegger, P. (2011). Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. The FASEB Journal. https://doi.org/10.1096/fj.11-191262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.